Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
Cytometry. Part B, Clinical Cytometry|June 19, 2015
Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphomaDavid Wu, Anju Thomas, Jonathan R FrommClinics in Laboratory Medicine|July 22, 2023
A Review of the Flow Cytometric Findings in Classic Hodgkin Lymphoma, Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte-Rich Large B Cell LymphomaFeras Ally, David Gajzer, Jonathan R FrommThe Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons|March 8, 2017
A Case Report of Heel Pain Mimicking Plantar Fasciitis and Osteosarcoma: A Unique Presentation of a Nora's LesionCalvin J Rushing, Diana E Rogers, Steven M Spinner, et al.American Journal of Clinical Pathology|February 21, 2009
Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificityJonathan R Fromm, Anju Thomas, Brent L WoodThe American Journal of Pathology|December 22, 2016
Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell SortingJonathan R Fromm, Anju Thomas, Brent L WoodJournal of Clinical Pathology|October 14, 2022
Predictors of risk of relapse in classic Hodgkin lymphomaJonathan R Fromm, Claire Tang, Kikkeri N NareshAdvances in Hematology|December 4, 2010
Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applicationsMikhail Roshal, Brent L Wood, Jonathan R FrommCytometry. Part B, Clinical Cytometry|July 22, 2014
Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissueDavid Wu, Camilla T Allen, Jonathan R FrommMethods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Flow cytometry for non-Hodgkin and classical Hodgkin lymphomaDavid Wu, Brent L Wood, Jonathan R FrommOncotargets and Therapy|January 1, 2014
Targeted therapy for Hodgkin lymphoma and systemic anaplastic large cell lymphoma: focus on brentuximab vedotinXueyan Chen, Lorinda A Soma, Jonathan R FrommPageof 9